Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: J Allergy Clin Immunol Pract. 2016 Sep 21;5(2):410–419.e4. doi: 10.1016/j.jaip.2016.08.001

FIGURE 1.

FIGURE 1

Baseline (dark bars) and posttriamcinolone (light bars) (A) ACQ scores and (B) self-reported asthma symptoms. SABA use in controlled severe asthma (C), in children who achieved control (D), and in children who did not (E). Dashed lines in panels A and C to E reflect the cut-point and best-fit lines, respectively.